Future Trends and Challenges of Molecular Imaging and AI Innovation: Proceedings of FASMI 2020

by Kang-Ping Lin (Editor), Ren-Shyan Liu (Editor), Bang-Hung Yang (Editor)

Overview

This volumes presents the proceedings of the FASMI 2020 conference, held at Taipei Veterans General Hospital on November 20-22, 2020. It presents contributions on all aspects of molecular imaging, discovered by leading academic scientists and researchers. It also provides a premier interdisciplinary treatment of recent innovations, trend, and concerns as well as practical challenges and solutions in Molecular Imaging and put an emphasis on Artificial Intelligence applied to Imaging Data. 
FASMI is the annual meeting of the Federation of Asian Societies for Molecular Imaging

Product Details

ISBN-13:	9783030927868
Publisher:	Springer-Verlag New York, LLC
Publication date:	02/22/2022
Series:	Springer Proceedings in Physics , #272
Sold by:	Barnes & Noble
Format:	eBook
File size:	34 MB
Note:	This product may take a few minutes to download.

Table of Contents

1. X-ray Tomography Study of 3D Hydrogel Structure.- 2. In-radiolabeling of Mesenchymal Stem Cell-derived Extracellular Vesicles for Quantitative in Vivo Imaging.- 3. A Comparative Study of Drug Distribution using Optoacoustic Tomography and Radionuclide-based Sampling in PEGylated Gold Nanostars-mediated Photothermal Therapy.- 4. CMR-derived Extracellular Volume Fraction is Associated with the Ventricular Wall Thickness in Patients with Hypertrophic Cardiomyopathy.-5. Upconversion nanoformulation for functional imaging.- 6. Three-Dimensional Tomography of Cellulose Nanofibers- Polypeptides Nanocomposite Hydrogels.- 7. Deep CNN with Conditional Random Field in Breast Cancer Metastasis Detection.- 8. Monitoring HDAC4 Expression in Alzheimer’s Disease Using [18F]TFAHA-PET.- 9. Study of A Position Decoding Method Making Imaging area Continuous for A Planar Positron Imaging Probe.- 10. The evaluation of novel PET/CT motion correction technique applied in Lung cancer patients.- 11. Evaluation of Radiolabeling PSMA-targeted Long Circulating Peptide as a Theranostic Agent in Human Prostate Tumor-bearing Mice.